Short Interest in Diversified Healthcare Trust – (NASDAQ:DHCNI) Drops By 34.9%

Diversified Healthcare Trust – (NASDAQ:DHCNI) saw a significant decrease in short interest in May. As of May 29th, there was short interest totaling 14,571 shares, a decrease of 34.9% from the May 14th total of 22,390 shares. Based on an average trading volume of 47,479 shares, the days-to-cover ratio is presently 0.3 days.

Diversified Healthcare Trust Stock Up 0.1%

Shares of Diversified Healthcare Trust stock traded up $0.02 during trading hours on Tuesday, hitting $18.23. The company’s stock had a trading volume of 3,307 shares, compared to its average volume of 72,171. Diversified Healthcare Trust has a 12 month low of $14.93 and a 12 month high of $19.09. The stock has a 50 day moving average of $18.16 and a 200 day moving average of $17.45.

Diversified Healthcare Trust Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, May 1st. Shareholders of record on Wednesday, April 15th were issued a $0.3516 dividend. This represents a $1.41 annualized dividend and a dividend yield of 7.7%. The ex-dividend date was Wednesday, April 15th.

Diversified Healthcare Trust (NASDAQ: DHCNI) is a publicly traded real estate investment trust (REIT) specializing in healthcare and life science properties. The company’s primary business activities include the acquisition, development, ownership and management of net‐leased medical office buildings, senior housing facilities and life science research and development assets. In addition to property investments, Diversified Healthcare Trust holds mortgage loans and preferred equity interests in the healthcare sector, offering diversified exposure to both real estate and structured financing arrangements.

The company’s portfolio spans a broad range of healthcare asset types, including medical office buildings leased to health systems and physician groups, senior living communities operated by leading care providers, and life science campuses serving biotechnology and pharmaceutical companies.